Photodynamic therapy in gynaecological neoplastic diseases

Journal of Photochemistry and Photobiology B: Biology

Volumn 36, Issue 2, 1996, Pages 193-197

  Corti, L ^a   Mazzarotto, R ^a   Belfontali, S ^a   De Luca, C ^a   Baiocchi, C ^a   Boso, C ^a   Calzavara, F ^a  

^a Adria General Hospital   (Italy)

Author keywords

Gynaecological cancers; Photodynamic therapy; Tumors

Indexed keywords

HEMATOPORPHYRIN; PHOTOFRIN II;

ADULT; AGED; ARGON LASER; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CARBON DIOXIDE LASER; CLINICAL ARTICLE; CONFERENCE PAPER; DYE LASER; FEMALE; GYNECOLOGIC CANCER; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL RATE; SYMPTOM; VAGINA CANCER;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; FEMALE; GENITAL NEOPLASMS, FEMALE; HEMATOPORPHYRINS; HUMANS; LASERS; MIDDLE AGED; PHOTOCHEMOTHERAPY; VAGINAL NEOPLASMS;

EID: 0030293859     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(96)07371-X     Document Type: Conference Paper

References (21)

1. [1] L.W. Brady, C.A. Perez and J.M. Bedwinek, Failure patterns in gynaecologic cancer, Int. J. Radiat. Oncol. Biol. Phys., 12 (1986) 549-557.
2. [2] J.T. Soper, A. Berchuck and W.T. Creasman, Pelvic exenteration: factors associated with major surgical morbidity, Gyn. Oncol., 35 (1989) 93-98.
3. [3] G.M. Sommers, P.W. Grigsby and C.A. Perez, Outcome of recurrent cervical carcinoma following definitive irradiation, Gyn. Oncol., 35 (1989) 150-155.
4. [4] G.R. Weiss, S. Green and E.V. Hannigan, A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma pf the uterine cervix: a southwest oncology group trial, Gyn. Oncol., 37 (1990) 354-358.
5. [5] W.M. Hogan, P. Littman and L. Griner, Results of radiation therapy given after radical hysterectomy, Cancer, 49 (1982) 1278-1285.
6. [6] M. Yudelev, A. Kuten and M. Tatcher, Correlations of dose and time-dose-fractionation factors (TDF) with treatment results and side effects in cancer of the uterine cervix, Gyn. Oncol., 23 (1986) 310-315.
7. [7] L. Corti, T. Maggino and L. Tomio, Photodynamic therapy (PDT) in gynaecological neoplasm: endogenous porphyrin, ProPc. Int. Meeting of Gynaecological Oncology, Venice, Italy, April 21-24, 1985.
8. [8] B.G. Ward, K.J. Forbes and P.A. Cowled, The treatment of vaginal recurrences of gynaecological malignancy with phototherapy following hematoporphyrin derivative pre-treatment, Am. J. Obst. Gynaecol., 142 (1992) 356-361.
9. [9] H. Soma and S. Nutahara, Cancer of the female genitalia, in Y. Hayata and T.J. Dougherty (eds.), Lasers and hematoporphyrin derivative in cancer, Igaku-Shoin, Tokyo, 1983, pp. 97-109.
10. [10] Y. Tokuda, Primary skin cancers, in Y. Hayata and T.J. Dougherty (eds), Lasers and hematophorphyrin derivative in cancer, Igaku-Shoin, Tokyo, 1983, pp. 88-96.
11. [11] K. Kubota, T. Kasai and H. Takamizawa, Experimental studies of photoradiation therapy (PRT) against human uterine cancer cell line, J. Jpn. Soc. Laser Med., 4 (1983) 85-86.
12. [12] M.A. Rettenmaier, M.R. Berman and P.J. Di Saia, Gynaecologic uses of photoradiation therapy, in D.R. Doiron and C.J. Gomer (eds), Porphyrin localization and treatment of tumors, Alan R. Liss, New York, 1984, p. 767.
13. [13] J.S. McCaughan, H.F. Schellhas and J. Lomano, Photodynamic therapy of gynaecologic neoplasms after presensitization with hematoporphyrin derivative. Lasers Surg. Med., 5 (1985) 491-498.
14. [14] R.V. Lobraico, S.M. Waldow and D.M. Harris, Photodyanmic therapy for cancer of the lower female genital tract. Colposc. Gynaecol. Laser Surg., 2 (1986) 185.
15. [15] R.V. Lobraico and L.I. Grossweiner, Thermal lasers and photodynamic therapy in gynaecology, in P. Spinelli, M. Dal Fante and R. Marchesini (eds.), Photodynamic therapy and biomedical lasers, Elsevier Science S.A., 1992, pp. 37-41.
16. [16] J.G. Huang, Photodynamic therapy for genitourinary carcinomas -report of 26 tumors in 17 patients, Chung-hua-Chung-Liu-Chih., 13 (1) (1991) 55-57.
17. [17] H. Hetzel, E. Muller-Holzner and C. Marth et al., Photodynamic therapy in patients with recurrent gynaecologic cancers, Geburtshilfe-Frauenheilkd., 53 (5) (1993) 333-336.
18. [18] L. Corti, L. Tomio and S. Maluta, Recurring gynaecologic cancer treated with photodynamic therapy, Photochem. Photobiol., 46 (5) (1987) 949-952.
19. [19] L. Corti, S. Maluta and L. Tomio, Phodynamic therapy in gynaecological cancer, Lasers Med. Sci., 4 (1989) 155.
20. [20] G. Dragoni, Elementi di radiobiologia, Casa Edn., Ambrosiana, Milan, 1968.
21. [21] S.M. Waldow, B.W. Henderson and T.J. Dougherty, Hyperthermic potentiation of photodynamic therapy employing photofrin I and II: comparison of results using three animal tumors model, Lasers Surg. Med., 7 (1) (1987) 12.